Advances in the Role of Chemokines in Microwave Ablation-Based Combinatorial Immunotherapy.

Abstract

Immunotherapy enhances antitumor immunity to eliminate malignant cells and has great potential to prevent tumor recurrence and distant metastasis. In addition to direct tumor destruction, microwave ablation (MWA) remodels the tumor immune microenvironment (TIME) and induces antitumor immune responses, providing a strong rationale for combination with immunotherapy. As key regulators of immune-cell trafficking and function, chemokines critically mediate the synergy between MWA and immunotherapy. In this review, we summarize the effects of MWA on the TIME, the central role of chemokine networks in this process, and recent advances in MWA-based combinatorial immunotherapy, including clinical progress. We also discuss current challenges and future directions to support the optimization of multimodal cancer therapy and improve clinical outcomes.

Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response
Jacobo Rogado, Elisabet González del Portillo, Diego Casado Elía +1
Frontiers in Oncology5 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossref
CT-guided hybrid cryo-thermal co-ablation versus microwave ablation for stage I renal cell carcinoma: a real-world propensity score-matched comparative study
Quantitative imaging in medicine and surgery29 Aug 2026Peer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
Long-Term Outcomes of Interventional Treatments for Lung Cancer Liver Metastases: Transarterial Chemoembolization and Microwave Ablation
Journal of clinical medicine25 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Efficacy and safety of ultrasound-guided microwave “Near-Total Ablation” for refractory hyperthyroidism: a retrospective study
Fenglin Wu, Shicong Song, Junyu Xue +4
Frontiers in endocrinology16 Oct 2026Peer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
Association between microwave ablation and remission in patients with Graves’ hyperthyroidism receiving continuous antithyroid drug treatment: a single-arm prospective study
Liu Liu, Ying Chen, Yueting Zhao +4
Quantitative imaging in medicine and surgery18 Sep 2026Peer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC

Cite

BibTeX RIS

BibTeX

@article{an2026advances,
  title = {{Advances in the Role of Chemokines in Microwave Ablation-Based Combinatorial Immunotherapy.}},
  author = {Ruijie An and Ningning He and Wendong Gu},
  journal = {Cancer science},
  year = {2026},
  month = oct,
  doi = {10.1111/cas.70565},
  url = {https://europepmc.org/article/MED/42897755},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Advances in the Role of Chemokines in Microwave Ablation-Based Combinatorial Immunotherapy.
AU  - Ruijie An
AU  - Ningning He
AU  - Wendong Gu
PY  - 2026
DA  - 2026/10/19
JO  - Cancer science
DO  - 10.1111/cas.70565
UR  - https://europepmc.org/article/MED/42897755
AB  - Immunotherapy enhances antitumor immunity to eliminate malignant cells and has great potential to prevent tumor recurrence and distant metastasis. In addition to direct tumor destruction, microwave ablation (MWA) remodels the tumor immune microenvironment (TIME) and induces antitumor immune responses, providing a strong rationale for combination with immunotherapy. As key regulators of immune-cell trafficking and function, chemokines critically mediate the synergy between MWA and immunotherapy. In this review, we summarize the effects of MWA on the TIME, the central role of chemokine networks in this process, and recent advances in MWA-based combinatorial immunotherapy, including clinical progress. We also discuss current challenges and future directions to support the optimization of multimodal cancer therapy and improve clinical outcomes.
SN  - 1347-9032
SN  - 1349-7006
ER  -

Abstract

Related

Cite